-
effectivehealthcare-admin.ahrq.gov/sites/default/files/nursing-home-safety_disposition-comments.pdf
May 27, 2016 - Avoidable decline in ADLS may
be viewed as harm not a potentially contributing factor to an adverse
event … Peer reviewer #5 Background Why is dementia not a contributing event? … issues as defined in Patient Safety
Organization Privacy Protection Center
(PSOPPC) Common Formats for Event … We focused on the 4 safety events as
currently identified in the PSOPPC
Common Formats for Event Reporting … We focused on the 4 safety events as
currently identified in the PSOPPC
Common Formats for Event Reporting
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antipsychotics-children-future_research.pdf
February 01, 2012 - For SGAs, adverse event profiles of various
SGAs showed that risperidone was favored over olanzapine … comparisons between and
within classes of 1st and 2nd generation antipsychotics for any shorter term adverse event … Cardiomyopathies
• Cardiac arrhythmias
• Agranulocytosis
• Extrapyramidal effects
General adverse event … evidence to favor placebo
over several 2nd generation antipsychotics with respect to several adverse event … for comparisons between and within classes of 1st and 2nd
generation antipsychotics for any adverse event
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/measuring-blood-pressure_research-protocol.pdf
April 11, 2011 - Summary of Protocol Amendments
In the event of protocol amendments, the date of each amendment will
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/procalcitonin_research-protocol.pdf
September 08, 2011 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: September 8, 2011
Evidence-based Practice Center Systematic Review Protocol
Project Title: Procalcitonin for Diagnosis and Management of Sepsis
Amendment Date(s) if applicable:
(Amendm…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/sleep-apnea_research-protocol.pdf
March 15, 2010 - Depression event (diagnosis, recurrence, etc.)
9. Intermediate or Surrogate outcomes
a. … Summary of Protocol Amendments
In the event of protocol amendments, the date of each amendment will
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/surveillance-report-1-nonopioid-pharm-chronic-pain.pdf
April 01, 2022 - No change in
conclusions
Abbreviations: AE=adverse event; CBD=cannabidiol; CR=controlled release; … with increased risk of withdrawal versus placebo (2.1% vs. 0%, p>0.05).6
The most common adverse event
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_executive.pdf
March 01, 2012 - Peto’s OR was chosen over relative risk when
the control event rate was exceptionally low (less than … Peto’s Odds Ratio (OR): An odds ratio is the ratio of an
event occurring in an exposed group to an event … Relative Risks (RRs): The ratio of an event occurring in
an exposed group to an event occurring in a
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-children_research.pdf
January 01, 2023 - expected to
slightly increase risk for both MI and SCD.10
According to a summary from the FDA’s Adverse Event … infarction) or an acute
condition leading immediately to SCD, it was not grounds for exclusion of the event
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-future_research.pdf
April 01, 2013 - dual therapy with pegylated interferon alfa-2a plus ribavirin
in risk of any assessed adverse event. … “treatment emergent” OR tolerab*
OR toxic* OR “adverse effect*” OR “adverse reaction*” OR “adverse event … “treatment emergent” OR tolerab* OR
toxic* OR “adverse effect*” OR “adverse reaction*” OR “adverse event … “treatment emergent” OR tolerab* OR
toxic* OR “adverse effect*” OR “adverse reaction*” OR “adverse event … week 4 SVR, HCV RNA seronegative by PCR
throughout 24-week off-treatment period
Safety - adverse event
-
effectivehealthcare-admin.ahrq.gov/products/stroke-afib-update/research-protocol
September 01, 2019 - , dementia)
When in therapeutic range
When non-adherent to medication
Previous thromboembolic event … patient characteristics; clinical settings; diagnostic tools; and intermediate, final, and adverse event … Example factors include narrow eligibility criteria and exclusion of those with comorbidities, event … Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event
-
effectivehealthcare-admin.ahrq.gov/products/patient-safety-drug-data/abstract
April 01, 2018 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/hip-fracture-pain_consumer.pdf
May 01, 2011 - years old) who is in a hospital because of a hip fracture
(a broken hip that occurs suddenly from an event
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/inguinal-hernia_research-protocol.pdf
August 15, 2011 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: August 15, 2011
1
Evidence-based Practice Center Systematic Review Protocol
Project Title: Comparative Effectiveness of Surgical Options for Inguinal Hernia
Protocol Posting Date: Apri…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_executive.pdf
April 01, 2012 - Overall adverse event
profiles appeared to be similar for biologic
DMARDs and placebo.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ambulatory-safety_research-protocol.pdf
July 24, 2015 - Summary of Protocol Amendments
In the event of protocol amendments, the date of each amendment will
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antiplatelet-treatment_research-protocol.pdf
November 22, 2011 - CYP2C19 alleles among different ethnic groups), comorbid conditions (that
may affect the baseline event … reactivity is an intermediate phenotype between exposure to a drug and occurrence of a
clinical event … (e.g., an arterial thrombotic event), we refer to tests of platelet reactivity as
“phenotypic tests … Summary of Protocol Amendments
In the event of protocol amendments, the date of each amendment will
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/delilberative-methods-design-gupta.pdf
January 11, 2017 - Goal Setting
Slide 5
Goal Setting
Jyoti Gupta, MPH,
Senior Public Engagement Associate
Public Agenda Speaker notes: This webinar is part of a large, three-year project, funded
by the Agency for Healthcare Research and Quality (AHRQ) and led by the American
Institutes for Research (AIR).
Slide 6
Purposes…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/study-design-framework_research.pdf
March 01, 2012 - Power Calculations for Superiority RCTs for Various 5-year Primary Event Rates in
the Comparator Arm … When sample size estimates are provided, the basis for the sample
size calculations (e.g., event rates … Power calculations for superiority RCTs for various 5-year primary event rates in the
comparator arm11 … Plotted are power calculations for six different 5-year primary event rates in the comparator arm … for a two-sided chi-squared test at the 0.05 level of
significance, and assuming a constant annual event
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ptsd-adult-treatment_executive.pdf
April 01, 2013 - Posttraumatic stress disorder (PTSD)
is a mental disorder that may develop
following exposure to a traumatic
event … posttraumatic stress disorder
Criterion Symptom or Description
Criterion A: Trauma (both) • Traumatic event … symptoms
(1 or more)
• Intrusive recollections of events
• Recurrent distressing dreams of the event … • Acting or feeling as if the traumatic event were recurring
• Distress at internal or external reminders … i.e., those that
treat PTSD by directly addressing thoughts, feelings, or
memories of the traumatic event
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND__0250_05-20-2010.pdf
January 01, 2010 - Effective Health Care
Topic Number(s): 0268a-b-c
Document Completion Date: 02-25-11
1
Results of Topic Selection Process & Next Steps
Treatment of atrial fibrillation (AF) and stroke prevention in AF will go forward for refinement as
systematic reviews. Primary prevention of AF will not go f…